Skip Nav Destination
Issues
1 January 2021
-
Cover Image
Cover Image
In this issue, Su, Chhabra, and colleagues demonstrate that PLK1, a mitotic regulator, and NOTCH1, a protein involved in cell fate determination, are positively correlated in melanoma and associated with patient survival. Further, combined inhibition of PLK1 and NOTCH was found to result in synergistic anti-proliferative effects. The cover image represents a tissue core from an in-house human melanoma tissue microarray containing multiple cases of melanomas and benign nevi. The cores were stained for S100 (green), PLK1 (red), NOTCH1 (orange), and DAPI (blue), followed by a multispectral quantitative fluorescence imaging analysis using Vectra scanner coupled with Nuance and InForm software. Read the full article on page 161. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1535-7163
EISSN 1538-8514
Highlights
Review
Small Molecule Therapeutics
Rapid Induction of the Unfolded Protein Response and Apoptosis by Estrogen Mimic TTC-352 for the Treatment of Endocrine-Resistant Breast Cancer
Balkees Abderrahman; Philipp Y. Maximov; Ramona F. Curpan; Sean W. Fanning; Jay S. Hanspal; Ping Fan; Charles E. Foulds; Yue Chen; Anna Malovannaya; Antrix Jain; Rui Xiong; Geoffrey L. Greene; Debra A. Tonetti; Gregory R.J. Thatcher; V. Craig Jordan
Author Choice
Targeting Oncogene mRNA Translation in B-Cell Malignancies with eFT226, a Potent and Selective Inhibitor of eIF4A
Peggy A. Thompson; Boreth Eam; Nathan P. Young; Sarah Fish; Joan Chen; Maria Barrera; Haleigh Howard; Eric Sung; Ana Parra; Jocelyn Staunton; Gary G. Chiang; Adina Gerson-Gurwitz; Christopher J. Wegerski; Andres Nevarez; Jeff Clarine; Samuel Sperry; Alan Xiang; Christian Nilewski; Garrick K. Packard; Theodore Michels; Chinh Tran; Paul A. Sprengeler; Justin T. Ernst; Siegfried H. Reich; Kevin R. Webster
TACIMA-218: A Novel Pro-Oxidant Agent Exhibiting Selective Antitumoral Activity
Jamilah Abusarah; Yun Cui; Nehme El-Hachem; Abed El-Hakim El-Kadiry; Ian Hammond-Martel; Hugo Wurtele; Annie Beaudry; Noël J.-M. Raynal; Francis Robert; Jerry Pelletier; Maja Jankovic; Francois Mercier; Samaneh Kamyabiazar; Borhane Annabi; Moutih Rafei
Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis–Addicted Breast Tumor Growth
Shauni Lien Geeraerts; Kim Rosalie Kampen; Gianmarco Rinaldi; Purvi Gupta; Mélanie Planque; Nikolaos Louros; Elien Heylen; Kaat De Cremer; Katrijn De Brucker; Stijn Vereecke; Benno Verbelen; Pieter Vermeersch; Joost Schymkowitz; Frederic Rousseau; David Cassiman; Sarah-Maria Fendt; Arnout Voet; Bruno P.A. Cammue; Karin Thevissen; Kim De Keersmaecker
Author Choice
Reprogramming of Nucleotide Metabolism Mediates Synergy between Epigenetic Therapy and MAP Kinase Inhibition
Tatiana Shorstova; Jie Su; Tiejun Zhao; Michael Dahabieh; Matthew Leibovitch; Mariana De Sa Tavares Russo; Daina Avizonis; Shivshankari Rajkumar; Ian R. Watson; Sonia V. del Rincón; Wilson H. Miller, Jr; William D. Foulkes; Michael Witcher
Disruption of SND1–MTDH Interaction by a High Affinity Peptide Results in SND1 Degradation and Cytotoxicity to Breast Cancer Cells In Vitro and In Vivo
Peng Li; Yunjiao He; Teng Chen; Kit-Ying Choy; Tsun Sing Chow; Iris L.K. Wong; Xinqing Yang; Wenqin Sun; Xiaochun Su; Tak-Hang Chan; Larry M.C. Chow
Large Molecule Therapeutics
Author Choice
Selective Tumor Cell Apoptosis and Tumor Regression in CDH17-Positive Colorectal Cancer Models using BI 905711, a Novel Liver-Sparing TRAILR2 Agonist
Juan Manuel García-Martínez; Shirley Wang; Cordula Weishaeupl; Andreas Wernitznig; Paolo Chetta; Catarina Pinto; Jason Ho; Darrin Dutcher; Philip N. Gorman; Rachel Kroe-Barrett; Joerg Rinnenthal; Craig Giragossian; Maria Antonietta Impagnatiello; Iñigo Tirapu; Frank Hilberg; Norbert Kraut; Mark Pearson; Klaus Peter Kuenkele
Author Choice
TriTACs, a Novel Class of T-Cell–Engaging Protein Constructs Designed for the Treatment of Solid Tumors
Richard J. Austin; Bryan D. Lemon; Wade H. Aaron; Manasi Barath; Patricia A. Culp; Robert B. DuBridge; Luke B. Evnin; Adrie Jones; Anand Panchal; Purbasa Patnaik; Vanitha Ramakrishnan; Sony S. Rocha; Pui Seto; Kenneth Sexton; Kathryn L. Strobel; Russell Wall; Stephen Yu; Timothy Z. Yu; Che-Leung Law; Patrick A. Baeuerle; Holger Wesche
Restoration of T-cell Effector Function, Depletion of Tregs, and Direct Killing of Tumor Cells: The Multiple Mechanisms of Action of a-TIGIT Antagonist Antibodies
Julie Preillon; Julia Cuende; Virginie Rabolli; Lucile Garnero; Marjorie Mercier; Noémie Wald; Angela Pappalardo; Sofie Denies; Diane Jamart; Anne-Catherine Michaux; Romain Pirson; Vincent Pitard; Martine Bagot; Shruthi Prasad; Erica Houthuys; Margreet Brouwer; Reece Marillier; Florence Lambolez; Joäo R. Marchante; Florence Nyawouame; Mathew J. Carter; Véronique Baron-Bodo; Anne Marie-Cardine; Mark Cragg; Julie Déchanet-Merville; Gregory Driessens; Catherine Hoofd
Companion Diagnostic, Pharmacogenomic, and Cancer Biomarkers
Author Choice
Circulating Tumor Cells and Biomarker Modulation with Olaratumab Monotherapy Followed by Olaratumab plus Doxorubicin: Phase Ib Study in Patients with Soft-Tissue Sarcoma
Javier Martín-Broto; Antonio López Pousa; Andrew S. Brohl; Brian A. Van Tine; Benjamin Powers; Silvia Stacchiotti; Jean-Yves Blay; James S. Hu; Gerard J. Oakley, III; Hong Wang; Anna M. Szpurka; Donna E. Levy; Gary Mo; Matteo Ceccarelli; Robin L. Jones
Cancer Biology and Translational Studies
Heat Shock Protein-90 Inhibition Alters Activation of Pancreatic Stellate Cells and Enhances the Efficacy of PD-1 Blockade in Pancreatic Cancer
Yuchen Zhang; Michael B. Ware; Mohammad Y. Zaidi; Amanda N. Ruggieri; Brian M. Olson; Hannah Komar; Matthew R. Farren; Ganji Purnachandra Nagaraju; Chao Zhang; Zhengjia Chen; Juan M. Sarmiento; Rafi Ahmed; Shishir K. Maithel; Bassel F. El-Rayes; Gregory B. Lesinski
Recombinant Orthopoxvirus Primes Colon Cancer for Checkpoint Inhibitor and Cross-Primes T Cells for Antitumor and Antiviral Immunity
Sang-In Kim; Anthony K. Park; Shyambabu Chaurasiya; Seonah Kang; Jianming Lu; Annie Yang; Venkatesh Sivanandam; Zhifang Zhang; Yanghee Woo; Saul J. Priceman; Yuman Fong; Susanne G. Warner
The Landscape of Glycogen Synthase Kinase-3 Beta Genomic Alterations in Cancer
Brittany A. Borden; Yasmine Baca; Joanne Xiu; Fabio Tavora; Ira Winer; Benjamin A. Weinberg; Ari M. Vanderwalde; Sourat Darabi; W. Michael Korn; Andrew P. Mazar; Francis J. Giles; Lorin Crawford; Howard Safran; Wafik S. El-Deiry; Benedito A. Carneiro
Models and Technologies
Author Choice
Antibody Co-Administration Can Improve Systemic and Local Distribution of Antibody–Drug Conjugates to Increase In Vivo Efficacy
Jose F. Ponte; Leanne Lanieri; Eshita Khera; Rassol Laleau; Olga Ab; Christopher Espelin; Neeraj Kohli; Bahar Matin; Yulius Setiady; Michael L. Miller; Thomas A. Keating; Ravi Chari; Jan Pinkas; Richard Gregory; Greg M. Thurber
Acknowledgment to Reviewers
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.